Ronald Portman
Overview
Explore the profile of Ronald Portman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antognini N, Portman R, Dong V, Webb N, Chand D
Ther Innov Regul Sci
. 2023 Dec;
58(2):286-302.
PMID: 38110788
The kidneys play a pivotal role in elimination of most drugs; therefore, a comprehensive understanding of renal physiology and pathology is important for those involved in drug development. High filtration...
2.
Fleming T, Garnett C, Conklin L, Corriol-Rohou S, Hariharan S, Hsu D, et al.
Ther Innov Regul Sci
. 2022 Sep;
57(1):109-120.
PMID: 36057747
Even with recent substantive improvements in health care in pediatric populations, considerable need remains for additional safe and effective interventions for the prevention and treatment of diseases in children. The...
3.
Noel G, Nelson R, Bucci-Rechtweg C, Portman R, Miller T, Green D, et al.
Ther Innov Regul Sci
. 2021 Apr;
55(4):773-778.
PMID: 33811302
Including adolescents in adult clinical trials can play an important role in making innovative new medicines available to children in a timelier fashion. Stakeholders involved in the processes leading to...
4.
Gamalo-Siebers M, Hampson L, Kordy K, Weber S, Nelson R, Portman R
Ther Innov Regul Sci
. 2019 May;
53(5):567-578.
PMID: 31084211
The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe. However, because pediatric patients are considered vulnerable...
5.
Leil T, Zee P, Suryawanshi S, Male C, Portman R
Ther Innov Regul Sci
. 2018 Sep;
47(5):557-565.
PMID: 30235580
Confirmation of efficacy in pediatric drug development has traditionally required large, fully powered efficacy studies that have proven to have major feasibility and ethical challenges. Extrapolation of efficacy in the...
6.
Spielberg S, Portman R
Ther Innov Regul Sci
. 2018 Sep;
49(5):613-614.
PMID: 30227028
No abstract available.
7.
Torok R, Li J, Kannankeril P, Atz A, Bishai R, Bolotin E, et al.
J Am Heart Assoc
. 2018 Feb;
7(4).
PMID: 29440007
No abstract available.
8.
Davis J, Baer G, Portman R, Nelson R, Storari L, Aranda J, et al.
Clin Ther
. 2017 Oct;
39(10):1959-1969.
PMID: 28987269
Because the highest rates of morbidity and mortality in neonates are seen in those born at <32 weeks' gestation, this group has the most urgent need for novel therapies to...
9.
Ward R, Benjamin D, Barrett J, Allegaert K, Portman R, Davis J, et al.
Pediatr Res
. 2017 Mar;
81(5):692-711.
PMID: 28248319
The study of medications among pediatric patients has increased worldwide since 1997 in response to new legislation and regulations, but these studies have not yet adequately addressed the therapeutic needs...
10.
Tamborlane W, Haymond M, Dunger D, Shankar R, Gubitosi-Klug R, Bethin K, et al.
Diabetes Care
. 2016 Feb;
39(3):323-9.
PMID: 26908928
No abstract available.